Azzad Asset Management’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $3.92M | Sell |
9,307
-57
| -0.6% | -$22.7K | 0.35% | 96 |
|
|
2026
Q2 | $3.39M | Buy |
9,364
+83
| +0.9% | +$28.4K | 0.3% | 107 |
|
|
2026
Q1 | $3.27M | Sell |
9,281
-76
| -0.8% | -$27.1K | 0.33% | 103 |
|
|
2025
Q4 | $3.06M | Buy |
9,357
+66
| +0.7% | +$20.9K | 0.3% | 113 |
|
|
2025
Q3 | $2.62M | Sell |
9,291
-96
| -1% | -$27.8K | 0.26% | 133 |
|
|
2025
Q2 | $2.62M | Buy |
9,387
+128
| +1% | +$36.3K | 0.28% | 136 |
|
|
2025
Q1 | $2.88M | Buy |
9,259
+172
| +2% | +$50.8K | 0.34% | 103 |
|
|
2024
Q4 | $2.37M | Buy |
9,087
+164
| +2% | +$48.7K | 0.46% | 69 |
|
|
2024
Q3 | $2.87M | Buy |
8,923
+2,766
| +45% | +$905K | 0.32% | 114 |
|
|
2024
Q2 | $1.92M | Buy |
+6,157
| New | +$1.81M | 0.23% | 170 |
|
|
2023
Q3 | – | Sell |
-7,188
| Closed | -$1.6M | – | 304 |
|
|
2023
Q2 | $1.6M | Buy |
7,188
+166
| +2% | +$38.5K | 0.21% | 171 |
|
|
2023
Q1 | $1.7M | Buy |
7,022
+94
| +1% | +$23.1K | 0.24% | 171 |
|
|
2022
Q4 | $1.82M | Sell |
6,928
-9,217
| -57% | -$2.47M | 0.29% | 140 |
|
|
2022
Q3 | $3.73M | Buy |
16,145
+135
| +0.8% | +$32.7K | 0.38% | 85 |
|
|
2022
Q2 | $3.83M | Buy |
16,010
+9,253
| +137% | +$2.27M | 0.38% | 91 |
|
|
2022
Q1 | $1.63M | Buy |
6,757
+1,172
| +21% | +$269K | 0.24% | 170 |
|
|
2021
Q4 | $1.26M | Sell |
5,585
-7,703
| -58% | -$1.63M | 0.17% | 206 |
|
|
2021
Q3 | $2.83M | Buy |
13,288
+605
| +5% | +$139K | 0.42% | 74 |
|
|
2021
Q2 | $3.09M | Buy |
12,683
+334
| +3% | +$82.2K | 0.46% | 60 |
|
|
2021
Q1 | $3.07M | Buy |
12,349
+304
| +3% | +$72.5K | 0.51% | 55 |
|
|
2020
Q4 | $2.77M | Buy |
12,045
+1,334
| +12% | +$308K | 0.5% | 58 |
|
|
2020
Q3 | $2.72M | Buy |
10,711
+1,563
| +17% | +$387K | 0.56% | 50 |
|
|
2020
Q2 | $2.16M | Buy |
9,148
+3,041
| +50% | +$694K | 0.51% | 62 |
|
|
2020
Q1 | $1.24M | Sell |
6,107
-8,957
| -59% | -$1.96M | 0.36% | 99 |
|
|
2019
Q4 | $3.58M | Buy |
15,064
+170
| +1% | +$37.5K | 0.42% | 81 |
|
|
2019
Q3 | $3.27M | Buy |
14,894
+9,389
| +171% | +$1.8M | 0.41% | 83 |
|
|
2019
Q2 | $1.01M | Buy |
5,505
+1,578
| +40% | +$283K | 0.28% | 146 |
|
|
2019
Q1 | $746K | Sell |
3,927
-12
| -0.3% | -$2.29K | 0.22% | 172 |
|
|
2018
Q4 | $767K | Buy |
+3,939
| New | +$768K | 0.26% | 154 |
|
Other funds holding AMGN
Azzad Asset Management's AMGN Position: Q3 2026 in Review
Azzad Asset Management reduced its Amgen (AMGN) stake by 0.61% in Q3 2026, selling an estimated $22.7K and leaving 9,307 shares worth $3.92M. The position accounts for 0.35% of the portfolio, ranked #96.
Azzad Asset Management first reported a position in AMGN in Q4 2018 and has held it in 29 quarters since. 3,263 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.
- Azzad Asset Management held 9,307 shares of Amgen worth $3.92M as of Q3 2026.
- Azzad Asset Management sold 57 Amgen shares in Q3 2026, an estimated $22.7K.
- Amgen made up 0.35% of Azzad Asset Management's portfolio in Q3 2026, its #96 holding.
- Azzad Asset Management first reported a position in Amgen in Q4 2018 and has held it in 29 quarters since.
- 3,263 funds tracked by Wall St. Rank held Amgen as of Q3 2026.
Based on Azzad Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.